Prognostic Biomarkers 3

• 5363 · PDF Validation of microenvironment gene signatures from FFPE to predict nasopharyngeal cancer prognosis Yi Ren, Wei Keat Teo, Bingcheng Wu, Joseph W. Foley, Chee Yit Lim, Serene Chor Hiang Siow, Han Lee Goh, Eugenia Li Ling Yeo, Enya Hui Wen Ong, Melvin Lee Kiang Chua, Jianjun Liu, Kwok Seng Loh, Raymond Tsang, Joshua K. Tay
• 5364 · PDF Neutrophilic skin infiltrates in patients with acute myeloid leukemia (AML) are clonal and associate with poor overall survival Gabby Tesfaye, Yazan Abu-Shihab, Deedra Nicolet, Jill Buss, Andrea Laganson, Catherine Chung, SANAM LOGHAVI, Benjamin Kaffenberger, Ann-Kathrin Eisfeld
• 5365 · PDF Clinicopathological and prognostic analyses of colorectal cancer with neuroendocrine differentiation Yuki Yasuda, Keigo Murakami, Hideaki Karasawa, Wataru Kosaka, Yota Akamori, Ichiro Ise, Tomoyuki Ono, Megumi Murakami, Yoshihiro Sato, Gumpei Yoshimatsu, Hideyuki Suzuki, Takashi Kamei, Shinobu Ohnuma, Toru Furukawa, Michiaki Unno
• 5366 · PDF Prognostic value of tumor-informed circulating tumor DNA in non-small cell lung cancer after curative treatment: real-world cohort with long-term follow-up Soyun Lim, Jisoo Lee, Julianne Jin, Anthony Wong, Youjin Oh, Sung Mi Yoon, Jeeyeon Lee, Joo Hee Park, Soowon Lee, Timothy Hong, Bella Kim, Sanghwa Kim, Liam Il-Young Chung, Young Kwang Chae
• 5367 · PDF Clinical and molecular features of CD276 (B7H3) in liver metastases of pancreatic cancer Go Igarashi, Shuichi Mitsunaga, Nobuaki Okumura, Kanae Inoue, Tomonao Taira, Taro Shibuki, Tomoyuki Satake, Masataka Amisaki, Mitsuhito Sasaki, Hideaki Takahashi, Hiroshi Imaoka, Masafumi Ikeda
• 5368 · PDF The prognostic role of pretreatment neutrophil-to-lymphocyte ratio in a multiethnic cohort of breast cancer patients Armaan Jamal, Lendy Chu, Jincong Q. Freeman, Rita Nanda, Olufunmilayo I. Olopade, Wenji Guo, Dezheng Huo
• 5369 5369 CCR8+ regulatory T cells represent a promising prognostic marker for non-small cell lung cancer (NSCLC) Santosh K. Singh, Manoj K. Mishra, Eric Flenaugh, Gabriella M. Oprea-Ilies, Brian M. Rivers, James W. Lillard, Shailesh Singh, Rajesh Singh
• 5370 · PDF Prognostic and metastasis-associated roles of IL-6 and IL-8 in patients with stage IV gastric cancer Jinsoo Jang, Chan Hee Park, Woo Sun Kwon, Tae Soo Kim, Sun Young Rha
• 5371 · PDF Annexin A3 expression is prevalent but highly variable in human cancer: A tissue microarray study involving 5,914 cancers from 105 tumor entities Clara von Bargen, Nayira Hakimi, Fiete Gehrisch, Anne Menz, Florian Lutz, Viktoria Chirico, Florian Viehweger, David Dum, Ria Schlichter, Andrea Hinsch, Christoph Fraune, Christian Bernreuther, Seyma Büyücek, Martina Kluth, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Nina Schraps, Katharina Möller, Andreas M. Luebke, Patrick Lebok, Guido Sauter, Maximilian Lennartz, Till S. Clauditz, Andreas H. Marx, Ronald Simon, Eike Burandt, Natalia Gorbokon, Maria C. Tsourlakis, Sarah Minner, Till Krech, Morton Freytag, Viktor Reiswich, Stefan Steurer
• 5372 · PDF Fragmentomics analysis of targeted hybrid capture NGS cfDNA gene panel data yields an orthogonal genomic dimension for developing a robust prognostic model for metastatic breast cancer patients Gregory M. Mayhew, Jonathan H. Shepherd, Jeff Burdine, Yoichiro Shibata, Gabriel V. Milburn, Michael V. Milburn, Kirk L. Pappan, James M. Davison, Kirk Beebe
• 5373 · PDF Prognostic impacts of skeletal muscle gene expression and cachexia in advanced colorectal cancer Vashti L. Bandy, Arunima Punjala, Praveen Bhoopathi, Vignesh Vudatha, KATARZYNA TYC, Mikhail G. Dozmorov, Leopoldo Fernandez, Andrew R. Judge, Sarah M. Judge, Anna Gibson
• 5374 · PDF Immune checkpoint protein expression of PD-1 shows prognostic significance in large B-cell lymphomas of the central nervous system Sara Francesca Santagostino, Derek M. Devine, John DeWitt, Alissa A. Thomas, Ashley K. Volaric
• 5375 · PDF Development of reference standards for clonal evolution and measurable residual disease in acute myeloid leukemia Colt W. Nash, Matthew G. Butler, Ojaswee Dahal, Jayanthi Ramprakash, Andrew T. Anfora, Yves Konigshofer
• 5376 5376 EGFR/RAS/SIAH pathway-centered biomarker-based prediction of tumor relapse/chemo-resistance/patient survival in TNBC Amy H. Tang, Mary L. Guye, Billur Samli, Janet S. Winston, Richard A. Hoefer
• 5377 · PDF Prediction of relapse risk in favorable outcome AML from DNA methylation data Jamie Endicott, Ruslan Strogantsev, CRISTINA TOGNON, Hisham Mohammed, Elie A. Traer
• 5378 · PDF GDF-15 reflects host physiological stress rather than tumor progression in colorectal cancer patients Tasuku Kaise, Hideaki Karasawa, Keigo Murakami, Ichiro Ise, Tomoyuki Ono, Megumi Murakami, Yoshihiro Sato, Gumpei Yoshimatsu, Hideyuki Suzuki, Takaaki Abe, Takashi Kamei, Shinobu Ohnuma, Toru Furukawa, Michiaki Unno
• 5379 · PDF Prognostic significance of STING expression in patients with resected lung adenocarcinoma Jung-Jyh Hung, Ying-Shiun Kao
• 5380 · PDF Prognostic utility of minimal residual disease detection using circulating tumor DNA in early-stage breast cancer: A systematic review and meta-analysis Panuch Eiamprapaporn, Thiti Susiriwatananont, Yaohua Ma, Hataiwan Ratanabunjerdkul, Panchanin Patanayindee, Lucksika Wanichtanom, E. Aubrey Thompson, Saranya Chumsri
• 5381 · PDF Integrated analysis for identification of risk stratification biomarkers for colon cancer Andrea J. O'Hara, Priya Roy, Dhwani Mulani, Ethan Stancliffe, Tom Cohen, Hemant Roy, Haythem Latif
• 5382 · PDF The Yin and Yang of sphingosine kinase 2 (SPHK2): Opposing regulation by nuclear and cytoplasmic localization in lung cancer progression Tsung-Ching Lai, Wei-Jiunn Lee, Jer-Hwa Chang, Ming-Hsien Chien
• 5383 · PDF Construction and assessment of the stemness-telomere survival risk framework (STSRF) for precision breast cancer therapy: Insights from multi-omic approaches Zhiyuan Bo, Jingpei Long, Fang Wan, Fangfang Chen, Jiajun Li, Zhengxiao Zhao

在会议检索中浏览本分会场